[{"address1": "642 Newtown Yardley Road", "address2": "Suite 100", "city": "Newtown", "state": "PA", "zip": "18940", "country": "United States", "phone": "215 944 6100", "website": "https://heliusmedical.com", "industry": "Medical Devices", "industryKey": "medical-devices", "industryDisp": "Medical Devices", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. Helius Medical Technologies, Inc. was incorporated in 2014 and is headquartered in Newtown, Pennsylvania.", "fullTimeEmployees": 22, "maxAge": 86400, "priceHint": 4, "previousClose": 0.9626, "open": 0.95, "dayLow": 0.95, "dayHigh": 1.1, "regularMarketPreviousClose": 0.9626, "regularMarketOpen": 0.95, "regularMarketDayLow": 0.95, "regularMarketDayHigh": 1.1, "beta": 1.588, "forwardPE": -0.32392028, "volume": 130469, "regularMarketVolume": 130469, "averageVolume": 452901, "averageVolume10days": 84390, "averageDailyVolume10Day": 84390, "bid": 0.9475, "ask": 1.03, "bidSize": 100, "askSize": 100, "marketCap": 2889120, "fiftyTwoWeekLow": 0.94, "fiftyTwoWeekHigh": 13.43, "priceToSalesTrailing12Months": 4.32503, "fiftyDayAverage": 2.49612, "twoHundredDayAverage": 5.91418, "currency": "USD", "enterpriseValue": -1125383, "floatShares": 2512230, "sharesOutstanding": 2963200, "sharesShort": 67237, "sharesShortPriorMonth": 72107, "sharesShortPreviousMonthDate": 1713139200, "dateShortInterest": 1715731200, "sharesPercentSharesOut": 0.026600001, "heldPercentInsiders": 0.0077600004, "heldPercentInstitutions": 0.042779997, "shortRatio": 0.09, "shortPercentOfFloat": 0.0275, "impliedSharesOutstanding": 3066010, "bookValue": 2.237, "priceToBook": 0.4358516, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -8872000, "trailingEps": -13.22, "forwardEps": -3.01, "lastSplitFactor": "1:50", "lastSplitDate": 1692230400, "enterpriseToRevenue": -1.685, "enterpriseToEbitda": 0.096, "52WeekChange": -0.88596493, "SandP52WeekChange": 0.26238096, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "HSDT", "underlyingSymbol": "HSDT", "shortName": "Helius Medical Technologies, In", "longName": "Helius Medical Technologies, Inc.", "firstTradeDateEpochUtc": 1403875800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "3364b2fa-c148-3feb-b3aa-1b060e1a4bc7", "messageBoardId": "finmb_266639642", "gmtOffSetMilliseconds": -14400000, "currentPrice": 0.975, "targetHighPrice": 4.0, "targetLowPrice": 4.0, "targetMeanPrice": 4.0, "targetMedianPrice": 4.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 1, "totalCash": 3638000, "totalCashPerShare": 1.438, "ebitda": -11748000, "totalDebt": 46000, "quickRatio": 2.665, "currentRatio": 3.505, "totalRevenue": 668000, "debtToEquity": 2.316, "revenuePerShare": 0.995, "returnOnAssets": -0.76075, "returnOnEquity": -2.2034, "freeCashflow": -5914875, "operatingCashflow": -10227000, "revenueGrowth": 0.216, "grossMargins": 0.12575, "operatingMargins": -25.303701, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-06-24"}]